Gastric cancer treatment: recent progress and future perspectives
WL Guan, Y He, RH Xu - Journal of hematology & oncology, 2023 - Springer
Gastric cancer (GC) is one of the most common malignancies worldwide. Most patients are
diagnosed at advanced stages due to the subtle symptoms of earlier disease and the low …
diagnosed at advanced stages due to the subtle symptoms of earlier disease and the low …
Current treatment and recent progress in gastric cancer
SS Joshi, BD Badgwell - CA: a cancer journal for clinicians, 2021 - Wiley Online Library
Gastric cancer is not a top‐10 malignancy in the United States but represents one of the
most common causes of cancer death worldwide. Biological differences between tumors …
most common causes of cancer death worldwide. Biological differences between tumors …
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
More than 1 million (1 089 103) new cases of gastric cancer were estimated globally in
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …
Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial
PURPOSE Neoadjuvant chemotherapy (NAC) has potential advantages over standard
postoperative chemotherapy for locally advanced colon cancer but requires formal …
postoperative chemotherapy for locally advanced colon cancer but requires formal …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …
tumor biological characteristics, treatment patterns, and drug selections between gastric …
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair/microsatellite instability–high gastric or esophagogastric …
PURPOSE In patients with resectable gastric/gastroesophageal junction (GEJ)
adenocarcinoma, surgery plus perioperative platinum-based chemotherapy is the standard …
adenocarcinoma, surgery plus perioperative platinum-based chemotherapy is the standard …
Microsatellite instability: a review of what the oncologist should know
K Li, H Luo, L Huang, H Luo, X Zhu - Cancer cell international, 2020 - Springer
The patients with high microsatellite instability (MSI-H)/mismatch repair deficient (dMMR)
tumors recently have been reported that can benefit from immunotherapy, and MSI can be …
tumors recently have been reported that can benefit from immunotherapy, and MSI can be …
[HTML][HTML] Microsatellite instability in Gastric Cancer: Between lights and shadows
Gastric cancer (GC) represents an important contributor to the global burden of cancer,
being one of the most common and deadly malignancies worldwide. According to TCGA and …
being one of the most common and deadly malignancies worldwide. According to TCGA and …
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
Genomic profiling can provide prognostic and predictive information to guide clinical care.
Biomarkers that reliably predict patient response to chemotherapy and immune checkpoint …
Biomarkers that reliably predict patient response to chemotherapy and immune checkpoint …
Predictive biomarkers in gastric cancer
C Röcken - Journal of cancer research and clinical oncology, 2023 - Springer
Predictive biomarkers are the mainstay of precision medicine. This review summarizes the
advancements in tissue-based diagnostic biomarkers for gastric cancer, which is considered …
advancements in tissue-based diagnostic biomarkers for gastric cancer, which is considered …